The verdict
Our read at a glance.
Whether infusing a tripeptide the body already makes produces skin lightening, detoxification, or general wellness benefits that justify intravenous administration.
- The signal
- Glutathione is a tripeptide of glutamate, cysteine and glycine, and its role in cellular antioxidant defence is not in question. The skin-lightening use is a different claim: reviews of the evidence describe it as substantially unproven, and the safety literature states there are no published clinical trials evaluating injectable glutathione for skin lightening, nor published guidance on dose or duration for that use.
- The unknown
- Whether infused glutathione meaningfully raises intracellular glutathione where it would need to act, what dose or duration would be required for any cosmetic effect, and whether any effect persists. Oral bioavailability is a separate and long-standing question that the skin-lightening literature does not resolve.
- Our read
- A real molecule with a real biological role, sold for a use that has essentially no trial evidence behind it and a documented mechanism for harm that comes mostly from the needle and the setting rather than the molecule. Being endogenous is not the same as being safe to infuse at high dose in a salon.
The mechanism
How it works.
Safety & regulatory boundary
The consequential part.
The Philippine FDA, the regulator most engaged with this practice, has approved injectable glutathione only as an adjunct in cisplatin chemotherapy and issued a public advisory against its use for skin lightening, citing possible hepatic, renal and neurological toxicity, Stevens-Johnson syndrome, and transmission of infectious agents when infusions are given in non-sterile settings by non-medical practitioners. That is a Philippine action, not a US FDA one. A published case describes systemic inflammatory response syndrome after a high-dose intravenous glutathione-containing infusion. Compounded drip formulations frequently pair it with high-dose vitamin C, which carries its own renal considerations.
What's next
What we're watching.
Any registered controlled trial of injectable glutathione for a cosmetic endpoint, pharmacokinetic work showing what infusion does to tissue glutathione, and further regulator action in other markets.
Context
Why this is discussed.
Glutathione genuinely is central to antioxidant defence, which makes the pitch sound mechanistically obvious, and drip clinics have turned it into a routine cosmetic service in many countries.
The evidence base
5 cited references.
Regulatory & labels1
Food and Drug Administration, Republic of the Philippines · 2019
Indexed literature (PubMed)4
Davids LM, van Wyk J, Khumalo NP, Jablonski NG (S Afr Med J) · 2016
Sonthalia S, Daulatabad D, Sarkar R (Indian J Dermatol Venereol Leprol) · 2016
Sonthalia S, Jha AK, Lallas A, Jain G, Jakhar D (Dermatol Pract Concept) · 2018
Sharma et al. (Cureus) · 2025
Keep reading